Ligand validation:3WBF

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3WBF_GOL_C_305	42%	91%	0.14	0.86	0.3	0.26	-	-	0	0	100%	1
3WBF_GOL_A_302	38%	91%	0.162	0.863	0.3	0.27	-	-	2	0	100%	1
3WBF_GOL_A_306	27%	91%	0.187	0.836	0.31	0.26	-	-	0	0	100%	1
3WBF_GOL_C_304	24%	91%	0.223	0.85	0.31	0.25	-	-	1	0	100%	1
3WBF_GOL_B_303	23%	90%	0.219	0.842	0.32	0.29	-	-	11	0	100%	1
3WBF_GOL_C_303	22%	91%	0.186	0.798	0.31	0.28	-	-	2	0	100%	1
3WBF_GOL_A_304	21%	91%	0.202	0.813	0.31	0.26	-	-	0	0	100%	1
3WBF_GOL_B_304	21%	91%	0.217	0.824	0.3	0.29	-	-	0	0	100%	1
3WBF_GOL_A_303	10%	91%	0.202	0.702	0.3	0.29	-	-	0	0	100%	1
3WBF_GOL_B_305	8%	91%	0.252	0.717	0.31	0.25	-	-	6	0	100%	1
3WBF_GOL_A_307	7%	91%	0.23	0.679	0.31	0.27	-	-	1	0	100%	1
3WBF_GOL_C_302	7%	92%	0.249	0.697	0.32	0.23	-	-	0	0	100%	1
3WBF_GOL_B_302	6%	91%	0.243	0.684	0.31	0.26	-	-	2	0	100%	1
3WBF_GOL_A_305	6%	93%	0.229	0.669	0.31	0.16	-	-	0	0	100%	1
3WBF_GOL_C_307	5%	91%	0.246	0.641	0.31	0.26	-	-	1	0	100%	1
3WBF_GOL_C_306	4%	91%	0.288	0.648	0.31	0.26	-	-	4	0	100%	1
3WB9_GOL_C_403	39%	91%	0.155	0.862	0.31	0.27	-	-	1	0	100%	1
3WBB_GOL_B_403	33%	90%	0.198	0.878	0.31	0.31	-	-	0	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.